Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Kobold

Showing results (131-140 of 177) with videos related to

Pageof 18
Sort By:
Frontiers in Medicine|January 23, 2026
Strengthening translational preclinical research through confirmatory multi-laboratory studiesSophia C Rotter, María Arroyo-Araujo, Natascha I Drude, et al.
Journal of Cancer Research and Clinical Oncology|October 24, 2019
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradoxStephan Kruger, Karoline Schirle, Michael Haas, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Medcomm|May 13, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70Khouloud Hachani, Mina Yazdi, Charlotte Carcopino, et al.
Science (New York, N.Y.)|March 31, 2018
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunityLucas Ferrari de Andrade, Rong En Tay, Deng Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2017
Cancer cells induce interleukin-22 production from memory CD4<sup>+</sup> T cells via interleukin-1 to promote tumor growthCornelia Voigt, Peter May, Adrian Gottschlich, et al.
British Journal of Cancer|October 20, 2022
Impact of the selective A2<sub>A</sub>R and A2<sub>B</sub>R dual antagonist AB928/etrumadenant on CAR T cell functionMatthias Seifert, Mohamed-Reda Benmebarek, Daria Briukhovetska, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Frontiers in Immunology|January 3, 2025
Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronismHanna F Nowotny, Tingting Zheng, Thomas Marchant Seiter, et al.
Blood Advances|February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Pageof 18

Showing results (131-140 of 177) with videos related to

Sort By:
Pageof 18
Frontiers in Medicine|January 23, 2026
Strengthening translational preclinical research through confirmatory multi-laboratory studiesSophia C Rotter, María Arroyo-Araujo, Natascha I Drude, et al.
Journal of Cancer Research and Clinical Oncology|October 24, 2019
Prolonged time to treatment initiation in advanced pancreatic cancer patients has no major effect on treatment outcome: a retrospective cohort study controlled for lead time bias and waiting time paradoxStephan Kruger, Karoline Schirle, Michael Haas, et al.
Frontiers in Immunology|May 17, 2021
Defective Interfering Genomes and the Full-Length Viral Genome Trigger RIG-I After Infection With Vesicular Stomatitis Virus in a Replication Dependent MannerAndreas Linder, Viktoria Bothe, Nicolas Linder, et al.
Medcomm|May 13, 2026
Development of CAR NK Cell Lines Selectively Targeting Cancer Cells Expressing Membrane Hsp70Khouloud Hachani, Mina Yazdi, Charlotte Carcopino, et al.
Science (New York, N.Y.)|March 31, 2018
Antibody-mediated inhibition of MICA and MICB shedding promotes NK cell-driven tumor immunityLucas Ferrari de Andrade, Rong En Tay, Deng Pan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 19, 2017
Cancer cells induce interleukin-22 production from memory CD4<sup>+</sup> T cells via interleukin-1 to promote tumor growthCornelia Voigt, Peter May, Adrian Gottschlich, et al.
British Journal of Cancer|October 20, 2022
Impact of the selective A2<sub>A</sub>R and A2<sub>B</sub>R dual antagonist AB928/etrumadenant on CAR T cell functionMatthias Seifert, Mohamed-Reda Benmebarek, Daria Briukhovetska, et al.
Journal for Immunotherapy of Cancer|May 19, 2023
Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunityLaura Fernandez-Rodriguez, Chiara Cianciaruso, Ruben Bill, et al.
Frontiers in Immunology|January 3, 2025
Sex-dependent modulation of T and NK cells and gut microbiome by low sodium diet in patients with primary aldosteronismHanna F Nowotny, Tingting Zheng, Thomas Marchant Seiter, et al.
Blood Advances|February 24, 2026
FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustionLisa Rohrbacher, Daniel Nixdorf, Helena Stadler, et al.
Pageof 18